The Enterprise Value as of June 2026 (TTM) for Polydex Pharmaceuticals Limited (POLXF) is 7.95M

According to Polydex Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 7.95M. This represents a change of 316.74% compared to the average of 1.91M of the last 4 quarters.

Polydex Pharmaceuticals Limited (POLXF) Historical Enterprise Value (quarterly & annually)

How has POLXF Enterprise Value performed in the past?

The mean historical Enterprise Value of Polydex Pharmaceuticals Limited over the last ten years is 11.16M. The current 7.95M Enterprise Value has changed 7.03% with respect to the historical average. Over the past ten years (40 quarters), POLXF's Enterprise Value was at its highest in in the April 2006 quarter at 29.23M. The Enterprise Value was at its lowest in in the April 2009 quarter at 1.42M.

Polydex Pharmaceuticals Limited (POLXF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Polydex Pharmaceuticals Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Polydex Pharmaceuticals Limited (POLXF) Average Enterprise Value

How has POLXF Enterprise Value performed in the past?

The current Enterprise Value of Polydex Pharmaceuticals Limited (POLXF) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Polydex Pharmaceuticals Limited (POLXF) Enterprise Value vs. Peers

How is POLXF’s Enterprise Value compared to its peers?

Polydex Pharmaceuticals Limited’s Enterprise Value is greater than Immune Therapeutics, Inc. (1.11M), less than Tetra Bio-Pharma Inc. (8.81M), greater than Forward Pharma A/S (-70770000.00), greater than Bionomics Limited (4.21M), less than Carebook Technologies Inc. (17.32M), greater than Tryp Therapeutics Inc. (7.53M), less than SQI Diagnostics Inc. (23.42M), less than CloudMD Software & Services Inc. (24.09M), less than BerGenBio ASA (130.24M), greater than Intellipharmaceutics International Inc. (7.21M),

Build a custom stock screener for Polydex Pharmaceuticals Limited (POLXF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Polydex Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Polydex Pharmaceuticals Limited (POLXF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Polydex Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.